Enhancement of proinflammatory and procoagulant responses to silica particles by monocyte-endothelial cell interactions
© Liu et al.; licensee BioMed Central Ltd. 2012
Received: 25 February 2012
Accepted: 11 September 2012
Published: 18 September 2012
Inorganic particles, such as drug carriers or contrast agents, are often introduced into the vascular system. Many key components of the in vivo vascular environment include monocyte-endothelial cell interactions, which are important in the initiation of cardiovascular disease. To better understand the effect of particles on vascular function, the present study explored the direct biological effects of particles on human umbilical vein endothelial cells (HUVECs) and monocytes (THP-1 cells). In addition, the integrated effects and possible mechanism of particle-mediated monocyte-endothelial cell interactions were investigated using a coculture model of HUVECs and THP-1 cells. Fe3O4 and SiO2 particles were chosen as the test materials in the present study.
The cell viability data from an MTS assay showed that exposure to Fe3O4 or SiO2 particles at concentrations of 200 μg/mL and above significantly decreased the cell viability of HUVECs, but no significant loss in viability was observed in the THP-1 cells. TEM images indicated that with the accumulation of SiO2 particles in the cells, the size, structure and morphology of the lysosomes significantly changed in HUVECs, whereas the lysosomes of THP-1 cells were not altered. Our results showed that reactive oxygen species (ROS) generation; the production of interleukin (IL)-6, IL-8, monocyte chemoattractant protein 1 (MCP-1), tumor necrosis factor (TNF)-α and IL-1β; and the expression of CD106, CD62E and tissue factor in HUVECs and monocytes were significantly enhanced to a greater degree in the SiO2-particle-activated cocultures compared with the individual cell types alone. In contrast, exposure to Fe3O4 particles had no impact on the activation of monocytes or endothelial cells in monoculture or coculture. Moreover, using treatment with the supernatants of SiO2-particle-stimulated monocytes or HUVECs, we found that the enhancement of proinflammatory response by SiO2 particles was not mediated by soluble factors but was dependent on the direct contact between monocytes and HUVECs. Furthermore, flow cytometry analysis showed that SiO2 particles could markedly increase CD40L expression in HUVECs. Our data also demonstrated that the stimulation of cocultures with SiO2 particles strongly enhanced c-Jun NH2-terminal kinase (JNK) phosphorylation and NF-κB activation in both HUVECs and THP-1 cells, whereas the phosphorylation of p38 was not affected.
Our data demonstrate that SiO2 particles can significantly augment proinflammatory and procoagulant responses through CD40–CD40L-mediated monocyte-endothelial cell interactions via the JNK/NF-κB pathway, which suggests that cooperative interactions between particles, endothelial cells, and monocytes may trigger or exacerbate cardiovascular dysfunction and disease, such as atherosclerosis and thrombosis. These findings also indicate that the monocyte-endothelial cocultures represent a sensitive in vitro model system to assess the potential toxicity of particles and provide useful information that may help guide the future design and use of inorganic particles in biomedical applications.
KeywordsEndothelial cells Monocytes Inflammation Particles Cell-cell interaction Signal transduction
Due to their excellent mechanical stability, high carrier capacity, easy variation of surface properties and inexpensive synthesis, inorganic nanoparticles have been widely studied in various medical fields, such as drug delivery, the discovery of biomarkers, and molecular diagnostics and gene therapy . Before nanoparticles are used for medical applications, their biological behavior and toxicological properties must be carefully assessed. Thus, it is necessary to understand the interactions of nanoparticles with biological systems.
For many intravenously administered nanoparticle-based drug carriers, the prolonged circulation properties can lead to the controlled release of therapeutic agents in the blood to targeted cells. However, the extended circulation time may increase the duration of the particles’ contact with blood components and endothelium and potentially cause undesirable host responses. Monocytes are among the first immune cells recruited to an invasion site in response to foreign materials. Recently, many studies have focused on nano-immunotoxicity and have found that some inorganic particles (e.g., hydroxyapatite particles, Nano-Co, and quantum dots) can activate monocytes to increase the release of proinflammatory cytokines and reactive oxygen species (ROS) [2–4]. Monocytes are a commonly used in vitro model for the innate immune response within a single cell type, but in the case of barrier defense, more complex models are required . The endothelium not only serves as a natural barrier in controlling the passage of particles from the blood into the surrounding tissues but also intricately links to innate immunity. Previous studies have shown that most inorganic particles (e.g., silica, zinc oxide, and alumina particles) can initiate an inflammatory response in endothelial cells (ECs), including the secretion of proinflammatory cytokines and the upregulation of vascular cellular adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and E-selectin, which are responsible for monocyte recruitment and adhesion [6–8]. Monocyte-endothelial cell adhesion and interactions have long been recognized for their essential roles in the process of inflammation and thrombosis . However, to date, while the direct effects of particles on ECs and monocytes have been widely discussed, far less effort has been put forth concerning the question of whether the particles can indirectly influence the host immune response through ECs or indirectly induce endothelial cell dysfunction via monocytes. Thus, the functional consequences and precise mechanisms of particle-induced monocyte-endothelial cell interactions must be further investigated. Ongoing applications of engineered nanoparticles in drug delivery systems and the molecular imaging field increase the urgency of such studies. In general, the interactions between monocytes and ECs may be direct, through ligand-receptor interactions, or indirect, through released factors (e.g., cytokines, growth factors or ROS). [10, 11] Recently, it has been reported that CD40/CD40L-mediated costimulation between monocytes and ECs leads to the induction of inflammatory and adhesive proteins in both cell types [12, 13]. Moreover, there is increasing evidence that particles can effectively upregulate CD40 expression in immune cells [14, 15]. Thus, it is likely that both soluble factors and costimulatory molecules play critical roles in particle-mediated monocyte-endothelial cell interactions, and further investigations are required to support this hypothesis.
Metal and silica particles (SiO2 particles) are among the most promising inorganic particles being developed for target therapy or molecular imaging [16–18]. Thus, Fe3O4 and SiO2 particles were chosen as test materials in the present study. As drug carriers or contrast agents, the distribution of particles into the vascular system appears highly probable. In our previous studies, we have found that SiO2 particles could directly induce inflammatory activation in ECs by the NF-κB pathway . Here, considering the complex architecture of the vascular system, we established a coculture model of THP-1 cells (monocytes) and human umbilical vein endothelial cells (HUVECs) to mimic the in vivo situation and, for the first time, investigated the integrated effects and possible mechanisms of the interactions between particles, monocytes and ECs. First, we assessed the direct effects of particles on THP-1 cells and HUVECs through the observation of cellular uptake and changes in cell viability. Subsequently, to investigate the functional consequences and molecular mechanisms of particle-mediated monocyte-endothelial cell interactions, we measured ROS levels, the release of proinflammatory cytokines, cellular adhesion molecules (CAMs), procoagulant marker expression, mitogen-activated protein kinases (MAPK), and the NF-κB activation of monocytes and ECs in particles-stimulated mono- and co-cultures. Moreover, to determine the role of soluble factors and cell-to-cell contact in particle-induced monocyte-endothelial cell interactions, we used the supernatant from THP-1 cells that had been stimulated with particles to treat HUVECs and vice versa and then examined the proinflammatory and procoagulant responses. In addition, to investigate the cell-to-cell contact-dependent mechanism, we also measured CD40L and CD40 expression in particle-stimulated THP-1 cells and HUVECs. Our studies provide a better understanding of the impact of nanoparticles on monocyte-endothelial cell interactions, which aids in the design of nanoparticles for various applications, including drug delivery or molecular imaging, especially when the cellular microenvironment near an atherosclerotic plaque site must be considered.
Results and discussion
Cytotoxicity of the particles
Monocytes amplify particle-induced endothelial cell inflammatory responses
EC-mediated proinflammatory and procoagulant activation of monocytes in response to SiO2 particles
Having shown that monocyte-endothelial cell interactions can enhance the endothelial inflammatory response to SiO2 particles, we analyzed monocyte activation to test whether this phenomenon is restricted to ECs. TNF-α and IL-1β were used as markers of monocyte activation. Notably, neither HUVECs nor monocytes produced TNF-α or IL-1β with SiO2-particle treatment. However, a massive amplification of TNF-α (~5-fold) and IL-1β (~10-fold) secretion was observed in response to SiO2 particles, but not Fe3O4 particles, in the monocyte/EC coculture compared with THP-1 cells or HUVECs alone stimulated with particles, suggesting that monocytes/ECs in coculture are more responsive to SiO2 particles than either cell type alone (Figures 6D-E). Many previous studies have shown that cocultures of multiple cell types have an increased sensitivity to microparticles and release more proinflammatory cytokines than one cell type alone [33–35]. It has been reported that mesoporous SiO2-particles hardly induce proinflammatory cytokines, such as TNF-α and IL-1β, in macrophages . However, an increased release of proinflammatory cytokines (TNF-α and IL-1β) in blood after injection with SiO2 particles has previously been observed in vivo . Taken together with our results, it is likely that SiO2 particles can indirectly activate monocytes through the stimulation of ECs.
Soluble factors and cell-to-cell contact-dependent mechanisms
Activation of the ROS, MAPK and NF-κB pathways
Taken together, our results indicate that SiO2 particles may induce CAMs, chemokines and receptor/ligand expression in ECs resulting in the preferential recruitment of monocytes from blood and their adhesion to ECs. The interaction of monocytes with ECs (via the CD40-CD40L pathway) results in the activation of both ECs and monocytes, which then release more proinflammatory cytokines or chemokines and induce the increased expression of CAMs or TF. Thus, a positive feedback loop may be created that could finally lead to cardiovascular dysfunction.
In summary, an in vitro model system of endothelial cell and monocyte coculture was developed that mimics cell communication within the bloodstream and could lead to a better understanding of the different cellular mechanisms related to the responses after exposure to inorganic particles. Our results indicated that the production of proinflammatory cytokines and chemokines and the expression of CD106, CD62E and TF are significantly enhanced to a greater degree in SiO2-particle-activated cocultures than in the individual cell types alone, suggesting that the co-cultures represent a sensitive in vitro model system in which to assess the potency of particles and illustrate that the safe application of nanomaterials requires the evaluation of both the direct and indirect proinflammatory and procoagulant potential of particles. Furthermore, our data also demonstrate that SiO2 particles can significantly augment proinflammatory and procoagulant responses through CD40–CD40L-mediated monocyte-endothelial cell interactions via the JNK/NF-κB pathway, suggesting that cooperative interactions between particles, ECs, and monocytes may trigger or exacerbate cardiovascular dysfunction and disease, such as atherosclerosis and thrombosis. The findings provide important information that may help guide the future design and use of inorganic particles in biomedical applications.
Preparation and characterization of SiO2 particles and Fe3O4 particles
SiO2 [Cat. No: 637246] and Fe3O4 particles [Cat. No: 637106] were purchased from Sigma-Aldrich (Sigma, St. Louis, MO, USA). The size and shape of these particles were examined under a transmission electron microscope (TEM) (JEOL, Tokyo, Japan). The specific surface area of these samples was determined by the Brunauer– Emmett–Teller (BET) method using a Surface Area Analyzer (ASAP2020, Micromeretics, GA, USA) after pre-preparation of the samples by heating them at 200°C in a stream of N2 in excess of 24 h. The hydrodynamic diameter of these particles in endothelial cell medium (ECM) (Sciencell, San Diego, USA) and RPMI 1640 medium (GIBCO, Scotland, UK) was measured with a Malvern Zetasizer instrument (Malvern Instruments, Worcestershire, UK). In the present study, before inoculation into the in vitro systems, these particles were sterilized by ethylene oxide, and the amount of residual styrene oxide of the particles was no more than 10 μg/g. A series of particle concentrations ranging from 25 μg/mL to 400 μg/mL was chosen to test the potential effects of the particles on HUVECs or THP-1 cells. The final particle dispersions were prepared freshly before use by serial dilution of the stock suspension (1 mg/mL) in ECM or RPMI 1640 medium (GIBCO, Scotland, UK), followed by intense vortexing. The endotoxin content of the samples was negative at the level of 1 EU/mL.
Cell preparation and culture
HUVECs were isolated and cultured using a modification of the method described by Jaffe . Briefly, the umbilical vein was rinsed three times with phosphate-buffered saline (PBS) containing 100 U/mL penicillin/streptomycin (GIBCO, Scotland, UK), filled with 0.1% collagenase I (Sigma, St. Louis, MO, USA), and incubated at 37°C for 15 min. Subsequently, the cells were collected by perfusion with PBS and centrifuged at 1,000 rpm for 10 min. After being harvested, the ECs were placed in 75-cm2 tissue culture flasks (Corning, US) and grown in ECM. HUVECs between the third and sixth passages were used in our experiments. The phenotype of the ECs was confirmed by performing immunofluorescence with monoclonal antibodies for the von Willebrand factor (Changdao Biotech, China). Human monocytes (THP-1) were purchased from the Cell Bank of Chinese Academy of Sciences (Shanghai, China) and cultured in RPMI 1640 medium with 10% fetal bovine serum (FBS) (BiochromAG, Berlin, Germany) and 100 U/mL penicillin/streptomycin.
For contact coculture of monocytes and HUVECs, 2 mL aliquots of THP-1 cells (1 × 106 cells/well) were added to 6-well plates onto confluent HUVEC layers (5 × 105 cells/well) in ECM. Experiments with contact cocultures were performed in the presence or absence of SiO2 particles for 24 h. To determine the role of soluble factors in monocyte-endothelial cell interactions, THP-1 cells (1 × 106 cells/mL) were treated with SiO2 particles for 24 h; the cell-free supernatant was then harvested and transferred to stimulate the HUVECs for 24 h. Likewise, HUVECs (5 × 105 cells/mL) were treated with the particles for 24 h, and the cell-free supernatant was transferred to stimulate the THP-1 cells for 24 h. The purity of THP-1 cells or HUVECs separated from cocultures was assessed with cell-specific surface markers (CD11a for monocytes and von willebrand factor (vWF) for HUVECs) using flow cytometry.
Cell viability assays
To determine the toxicity levels of the particles, cell viability was measured using the MTS method, a type of mitochondrial succinate dehydrogenase assay (Cell Titer 96 Aqueous non-radioactive cell proliferation assay) (Promega, Madison, WI). HUVECs and THP-1 cell cultures were individually prepared at approximately 20,000 cells per well in 96-well plates. The monolayer of HUVECs was approximately 70-80% confluent after 24 h. Serial dilutions of particles (25, 50, 100, 200, and 400 μg/mL) were added, and the cultures were incubated for 24 h. Twenty milliliters of MTS was then added to each well, and the plates were incubated for 4 h at 37°C in an atmosphere of 5% CO2 and 100% humidity. The absorbance of formazan was measured at 490 nm using a microplate reader (Labsystems Dragon Wellscan MK3, Finland).
To determine the cellular uptake and localization of the particles, HUVECs and THP-1 cells were individually exposed to particles for 24 h and analyzed by electron microscopy. For TEM studies, HUVECs and THP-1 cells were seeded onto a 6-well plate. After incubation for 24 h with particles (100 μg/mL), the excess medium was removed, and the cells were washed with PBS solution, trypsinized and centrifuged. Then, the cell pellets were fixed in a 0.1 M PBS solution containing 2.5% glutaraldehyde for 4 h. The cells were dehydrated through an ethanol series (70% for 15 min, 90% for 15 min, and 100% for 15 min twice) and embedded in Epon Araldite resin (polymerization at 65°C for 15 h). Thin sections containing the cells were placed on the grids and stained for 1 min each with 4% uranyl acetate (in acetone: water, 1:1) and 0.2% Raynolds lead citrate (in water), air dried, and imaged under a transmission electron microscope.
Intracellular ROS measurement
The production of ROS was measured by flow cytometry using DCFH-DA (Applygen, Beijing, China). Briefly, a 10 mM DCFH-DA stock solution (in methanol) was diluted 4,000-fold in cell culture medium without serum to yield a 2.5 μM working solution. After the exposure of HUVECs or THP-1 cells to SiO2 particles (100 μg/mL) in cocultures or monocultures for 24 h, the cells in 6-well plates were washed twice with PBS and incubated in 2 mL of the working solution of DCFH-DA at 37°C in the dark for 30 min. The cells were then washed twice with cold PBS and resuspended in PBS for the analysis of intracellular ROS with a FACScan flow cytometer (Becton Dickinson, San Jose, CA). DCFH fluorescence emission was collected with a 530 nm band-pass filter. The mean fluorescence intensity (MFI) of 104 cells was quantified using Cell Quest software (Becton Dickinson, USA).
For the analysis of cytokines (IL-6, IL-8, IL-1β, MCP-1 and TNF-α), the supernatants of HUVECs or THP-1 cells in cocultures or monocultures exposed to particles (100 μg/mL) were collected after 24 h, immediately centrifuged to remove the cells, and then frozen at −80°C until the analysis was performed. The amounts of IL-6, IL-8, MCP-1 IL-1β and TNF-α were quantified with an immunoassay kit (R&D Systems, Oxford, UK) according to the manufacturer’s instructions.
Immunofluorescence flow cytometry
The levels of surface markers expressed on HUVECs and the procoagulant phenotype of THP-1 cells were assessed using flow cytometry. After 24 h of coculture or monoculture in the absence or presence of SiO2 particles (100 μg/mL), THP-1 cells were separated and harvested by centrifugation, while HUVEC monolayers, seeded in the 6-well plates, were released from the wells after washing with PBS. The following mouse anti-human monoclonal antibodies were used: ICAM-1 (CD54-PE, eBioscience, San Diego, USA), VCAM-1 (CD106-FITC, BD Biosciences, San Diego, USA), E-selectin (CD62E-APC, BD Biosciences, San Diego, USA), tissue factor (TF) (CD142-PE, BD Biosciences, San Diego, USA), CD11a (Biolegend, San Diego, USA), and vWF ( BD Biosciences, San Diego, USA). In addition, FITC- and APC-conjugated antibodies specific for human CD40 and CD40L (BD Biosciences, San Diego, USA), respectively, were also used to determine the expression of the costimulatory molecules on HUVECs and THP-1 cells. After exposure to particles (100 μg/mL) for 24 h, HUVECs and THP-1 cells were collected and labeled with the above-mentioned specific antibodies at room temperature (RT) for 45 min in the dark, washed extensively, and then subsequently fixed with 1% paraformaldehyde. All samples were analyzed with a BD flow cytometer. The data were analyzed with Cell Quest software.
Western blot analysis
Total cellular protein extracts were prepared as described in a previous study . Briefly, after a 24-h coculture or monoculture in the absence or presence of SiO2 particles (100 μg/mL), as indicated, HUVECs or THP-1 cells were washed once with ice-cold PBS and lysed in ice-cold lysis buffer [50 mM Tris–HCl, 150 mM NaCl, 1% NP-40, 0.1% sodium dodecyl sulfate (SDS), Applygen, Beijing, China] containing 1 mM phenylmethylsulphonyl fluoride (PMSF) (Sigma, St. Louis, MO, USA) and phosphatase inhibitor cocktail (Sigma, St. Louis, MO, USA) for 30 min. After centrifuging the lysates at 12,000 rpm and 4°C for 10 min, the supernatants were collected and stored at −80°C until used. The protein concentrations of these extracts were determined by performing a bicinchoninic acid (BCA) protein assay (Pierce, Rockford, USA). Equal amounts of the lysate proteins (40 μg) were then loaded onto SDS-polyacrylamide gels (10-12% separation gels) and electrophoretically transferred to nitrocellulose (NC) membranes (Amersham Biosciences, US). After blocking with 5% nonfat milk in Tris-buffered saline (TBS) containing 0.05% Tween-20 (TBST) for 1 h at RT, the membrane was respectively incubated with anti-p-p38, p-p-JNK, JNK (1:1,000, rabbit polyclonal antibodies, Bioworld Technology, USA), anti-p-38 (1:1,000, rabbit polyclonal antibodies, CST, USA), β-actin (1:1,000, a mouse polyclonal antibody, Santa Cruz Biotechnology, CA) at 4°C overnight, washed with TBST, and incubated with a horseradish peroxidase-conjugated anti-rabbit IgG/anti-mouse IgG secondary antibody at 37°C for 1 h. The antibody-bound proteins were detected using the ECL chemiluminescence reagent (Millipore, USA).
Electrophoretic mobility shift assay (EMSA)
The EMSA is classically used to detect the activity of transcription factors and relies upon the principle that DNA bound to protein has decreased mobility through a polyacrylamide gel matrix relative to the corresponding free, unbound DNA. In the present study, the NF-κB activation in HUVECs and THP-1 cells was assessed by EMSA. Briefly, after a 24-h coculture or monoculture in the absence or presence of SiO2 particles (100 μg/mL), as indicated, nuclear extracts of HUVECs or THP-1 cells were prepared as described by the instructions for Nuclear and Cytoplasmic Extraction Reagents (Pierce, Rockford, USA). Protein concentrations were quantified by the BCA protein assay. Ten milligrams of nuclear protein was incubated in binding buffer containing 50 ng/μL Poly (dI·dC), 2.5% Glycerol, 0.05% NP-40, 5 mM MgCl2 and 20 fmol Biotin end-labeled oligonucleotides at RT for 20 min. The labeled oligonucleotides had the following sequences: 5′- AGT TGA GGG GAC TTT CCC AGG C - 3′ and 5′- GCC TGG GAA AGT CCC CTC AAC T - 3′. Cold competition experiments were performed by adding a 100-fold molar excess of unlabeled oligonucleotides. Protein–DNA complexes were separated from the free DNA probe by electrophoresis through 4% native polyacrylamide gels. Gels were dried, and then, the protein–DNA complexes were visualized by the ECL chemiluminescence system.
Data were expressed as the mean ± SD or the mean ± SEM. Statistical comparisons of the means were performed using one-way analysis of variance (ANOVA) with the software SAS 6.12. The differences were considered to be significant when the p value was less than 0.05.
Ethical approval was given by the independent ethics committee of Shanghai Ninth People’s affiliated to Shanghai JiaoTong University, School of Medicine with the following reference number: 2010–43. Written informed consent was obtained from the patient for publication of this report and any accompanying images.
This work was supported by grants from the Natural Science Foundation of China (no. 30670556, no. 31070843), the Shanghai Sci-Tech Committee Foundation (0752 nm026), the Shanghai Leading Academic Discipline Project (no. S30206), and the Major Program of the National Natural Science Foundation of China (no.81190132).
- Sekhon BS, Kamboj SR: Inorganic nanomedicine–part 1. Nanomedicine 2010,6(4):516–522. 10.1016/j.nano.2010.04.004PubMedView ArticleGoogle Scholar
- Grandjean-Laquerriere A, Laquerriere P, Guenounou M, Laurent-Maquin D, Phillips TM: Importance of the surface area ratio on cytokines production by human monocytes in vitro induced by various hydroxyapatite particles. Biomaterials 2005,26(15):2361–2369. 10.1016/j.biomaterials.2004.07.036PubMedView ArticleGoogle Scholar
- Wan R, Mo Y, Zhang X, Chien S, Tollerud DJ, Zhang Q: Matrix metalloproteinase-2 and −9 are induced differently by metal nanoparticles in human monocytes: The role of oxidative stress and protein tyrosine kinase activation. Toxicol Appl Pharmacol 2008,233(2):276–285. 10.1016/j.taap.2008.08.022PubMed CentralPubMedView ArticleGoogle Scholar
- Lee HM, Shin DM, Song HM, Yuk JM, Lee ZW, Lee SH, Hwang SM, Kim JM, Lee CS, Jo EK: Nanoparticles up-regulate tumor necrosis factor-alpha and CXCL8 via reactive oxygen species and mitogen-activated protein kinase activation. Toxicol Appl Pharmacol 2009,238(2):160–169. 10.1016/j.taap.2009.05.010PubMedView ArticleGoogle Scholar
- Boraschi D, Costantino L, Italiani P: Interaction of nanoparticles with immunocompetent cells: nanosafety considerations. Nanomedicine (Lond) 2012,7(1):121–131. 10.2217/nnm.11.169View ArticleGoogle Scholar
- Gojova A, Guo B, Kota RS, Rutledge JC, Kennedy IM, Barakat AI: Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle composition. Environ Health Perspect 2007,115(3):403–409.PubMed CentralPubMedView ArticleGoogle Scholar
- Oesterling E, Chopra N, Gavalas V, Arzuaga X, Lim EJ, Sultana R, Butterfield DA, Bachas L, Hennig B: Alumina nanoparticles induce expression of endothelial cell adhesion molecules. Toxicol Lett 2008,178(3):160–166. 10.1016/j.toxlet.2008.03.011PubMedView ArticleGoogle Scholar
- Liu X, Sun J: Endothelial cells dysfunction induced by silica nanoparticles through oxidative stress via JNK/P53 and NF-kappaB pathways. Biomaterials 2010,31(32):8198–8209. 10.1016/j.biomaterials.2010.07.069PubMedView ArticleGoogle Scholar
- Mestas J, Ley K: Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc Med 2008,18(6):228–232. 10.1016/j.tcm.2008.11.004PubMed CentralPubMedView ArticleGoogle Scholar
- Gawad A, Ptak-Belowska A, Brzozowski T, Pawlik WW: Monocytes and vascular endothelial cells apoptosis. Role of p-HSP27. J Physiol Pharmacol 2009,60(4):55–61.PubMedGoogle Scholar
- Woller G, Brandt E, Mittelstadt J, Rybakowski C, Petersen F: Platelet factor 4/CXCL4-stimulated human monocytes induce apoptosis in endothelial cells by the release of oxygen radicals. J Leukoc Biol 2008,83(4):936–945. 10.1189/jlb.0907592PubMedView ArticleGoogle Scholar
- Chakrabarti S, Rizvi M, Pathak D, Kirber MT, Freedman JE: Hypoxia influences CD40-CD40L mediated inflammation in endothelial and monocytic cells. Immunol Lett 2009,122(2):170–184. 10.1016/j.imlet.2008.12.010PubMedView ArticleGoogle Scholar
- Chakrabarti S, Blair P, Freedman JE: CD40–40 L signaling in vascular inflammation. J Biol Chem 2007,282(25):18307–18317. 10.1074/jbc.M700211200PubMedView ArticleGoogle Scholar
- Li A, Qin L, Zhu D, Zhu R, Sun J, Wang S: Signalling pathways involved in the activation of dendritic cells by layered double hydroxide nanoparticles. Biomaterials 2010,31(4):748–756. 10.1016/j.biomaterials.2009.09.095PubMedView ArticleGoogle Scholar
- Kim S, Oh WK, Jeong YS, Hong JY, Cho BR, Hahn JS, Jang J: Cytotoxicity of, and innate immune response to, size-controlled polypyrrole nanoparticles in mammalian cells. Biomaterials 2010,32(9):2342–2350.PubMedView ArticleGoogle Scholar
- Benezra M, Penate-Medina O, Zanzonico PB, Schaer D, Ow H, Burns A, DeStanchina E, Longo V, Herz E, Iyer S, et al.: Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. J Clin Invest 2011,121(7):2768–2780. 10.1172/JCI45600PubMed CentralPubMedView ArticleGoogle Scholar
- He Q, Shi J, Chen F, Zhu M, Zhang L: An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles. Biomaterials 2010,31(12):3335–3346. 10.1016/j.biomaterials.2010.01.015PubMedView ArticleGoogle Scholar
- Swierczewska M, Lee S, Chen X: Inorganic nanoparticles for multimodal molecular imaging. Mol Imaging 2011,10(1):3–16.PubMed CentralPubMedGoogle Scholar
- Lankoff A, Sandberg WJ, Wegierek-Ciuk A, Lisowska H, Refsnes M, Sartowska B, Schwarze PE, Meczynska-Wielgosz S, Wojewodzka M, Kruszewski M: The effect of agglomeration state of silver and titanium dioxide nanoparticles on cellular response of HepG2, A549 and THP-1 cells. Toxicol Lett 2012,208(3):197–213. 10.1016/j.toxlet.2011.11.006PubMedView ArticleGoogle Scholar
- Drescher D, Orts-Gil G, Laube G, Natte K, Veh RW, Osterle W, Kneipp J: Toxicity of amorphous silica nanoparticles on eukaryotic cell model is determined by particle agglomeration and serum protein adsorption effects. Anal Bioanal Chem 2011,400(5):1367–1373. 10.1007/s00216-011-4893-7PubMedView ArticleGoogle Scholar
- Gualtieri M, Skuland T, Iversen TG, Lag M, Schwarze P, Bilanicova D, Pojana G, Refsnes M: Importance of agglomeration state and exposure conditions for uptake and pro-inflammatory responses to amorphous silica nanoparticles in bronchial epithelial cells. Nanotoxicology 2011, : . 10.3109/17435390.2011.604441Google Scholar
- L’Azou B, Jorly J, On D, Sellier E, Moisan F, Fleury-Feith J, Cambar J, Brochard P, Ohayon-Courtes C: In vitro effects of nanoparticles on renal cells. Particle and fibre toxicology 2008, 5: 22. 10.1186/1743-8977-5-22PubMed CentralPubMedView ArticleGoogle Scholar
- Monteiro-Riviere NA, Inman AO, Zhang LW: Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol Appl Pharmacol 2009,234(2):222–235. 10.1016/j.taap.2008.09.030PubMedView ArticleGoogle Scholar
- Zhao F, Zhao Y, Liu Y, Chang X, Chen C: Cellular Uptake, Intracellular Trafficking, and Cytotoxicity of Nanomaterials. Small 2011,7(10):1322–1337. 10.1002/smll.201100001PubMedView ArticleGoogle Scholar
- Thurn KT, Arora H, Paunesku T, Wu A, Brown EM, Doty C, Kremer J, Woloschak G: Endocytosis of titanium dioxide nanoparticles in prostate cancer PC-3 M cells. Nanomedicine 2011,7(2):123–130. 10.1016/j.nano.2010.09.004PubMed CentralPubMedView ArticleGoogle Scholar
- Al-Rawi M, Diabate S, Weiss C: Uptake and intracellular localization of submicron and nano-sized SiO particles in HeLa cells. Arch Toxicol 2011,85(7):813–826. 10.1007/s00204-010-0642-5PubMedView ArticleGoogle Scholar
- He Q, Zhang Z, Gao Y, Shi J, Li Y: Intracellular localization and cytotoxicity of spherical mesoporous silica nano- and microparticles. Small 2009,5(23):2722–2729. 10.1002/smll.200900923PubMedView ArticleGoogle Scholar
- Libby P: Inflammation in atherosclerosis. Nature 2002,420(6917):868–874. 10.1038/nature01323PubMedView ArticleGoogle Scholar
- Ito T, Ikeda U: Inflammatory cytokines and cardiovascular disease. Curr Drug Targets Inflamm Allergy 2003,2(3):257–265. 10.2174/1568010033484106PubMedView ArticleGoogle Scholar
- Ikeda U, Ikeda M, Oohara T, Oguchi A, Kamitani T, Tsuruya Y, Kano S: Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. Am J Physiol 1991,260(5 Pt 2):H1713-H1717.PubMedGoogle Scholar
- Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone MA Jr, Luster AD, Luscinskas FW, Rosenzweig A: MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999,398(6729):718–723. 10.1038/19546PubMedView ArticleGoogle Scholar
- Zhu MT, Wang B, Wang Y, Yuan L, Wang HJ, Wang M, Ouyang H, Chai ZF, Feng WY, Zhao YL: Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: Risk factors for early atherosclerosis. Toxicol Lett 2011,203(2):162–171. 10.1016/j.toxlet.2011.03.021PubMedView ArticleGoogle Scholar
- Alfaro-Moreno E, Nawrot TS, Vanaudenaerde BM, Hoylaerts MF, Vanoirbeek JA, Nemery B, Hoet PH: Co-cultures of multiple cell types mimic pulmonary cell communication in response to urban PM10. Eur Respir J 2008,32(5):1184–1194. 10.1183/09031936.00044008PubMedView ArticleGoogle Scholar
- Herseth JI, Refsnes M, Lag M, Schwarze PE: Role of IL-1 beta and COX2 in silica-induced IL-6 release and loss of pneumocytes in co-cultures. Toxicol In Vitro 2009,23(7):1342–1353. 10.1016/j.tiv.2009.06.031PubMedView ArticleGoogle Scholar
- Kasper J, Hermanns MI, Bantz C, Maskos M, Stauber R, Pohl C, Unger RE, Kirkpatrick JC: Inflammatory and cytotoxic responses of an alveolar-capillary coculture model to silica nanoparticles: Comparison with conventional monocultures. Part Fibre Toxicol 2011,8(1):6. 10.1186/1743-8977-8-6PubMed CentralPubMedView ArticleGoogle Scholar
- Lee S, Yun HS, Kim SH: The comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosis. Biomaterials 2011,32(35):9434–9443. 10.1016/j.biomaterials.2011.08.042PubMedView ArticleGoogle Scholar
- Park EJ, Park K: Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro. Toxicol Lett 2009,184(1):18–25. 10.1016/j.toxlet.2008.10.012PubMedView ArticleGoogle Scholar
- Chu AJ: Tissue factor upregulation drives a thrombosis-inflammation circuit in relation to cardiovascular complications. Cell Biochem Funct 2006,24(2):173–192. 10.1002/cbf.1200PubMedView ArticleGoogle Scholar
- Tavano R, Segat D, Reddi E, Kos J, Rojnik M, Kocbek P, Iratni S, Scheglmann D, Colucci M, Echevarria IM, et al.: Procoagulant properties of bare and highly PEGylated vinyl-modified silica nanoparticles. Nanomedicine (Lond) 2010,5(6):881–896. 10.2217/nnm.10.65View ArticleGoogle Scholar
- Neumann FJ, Ott I, Marx N, Luther T, Kenngott S, Gawaz M, Kotzsch M, Schomig A: Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. Arterioscler Thromb Vasc Biol 1997,17(12):3399–3405. 10.1161/01.ATV.17.12.3399PubMedView ArticleGoogle Scholar
- Kristovich R, Knight DA, Long JF, Williams MV, Dutta PK, Waldman WJ: Macrophage-mediated endothelial inflammatory responses to airborne particulates: impact of particulate physicochemical properties. Chem Res Toxicol 2004,17(10):1303–1312. 10.1021/tx049893pPubMedView ArticleGoogle Scholar
- Wagner AH, Guldenzoph B, Lienenluke B, Hecker M: CD154/CD40-mediated expression of CD154 in endothelial cells: consequences for endothelial cell-monocyte interaction. Arterioscler Thromb Vasc Biol 2004,24(4):715–720. 10.1161/01.ATV.0000122853.99978.b1PubMedView ArticleGoogle Scholar
- Kalyanaraman B, Darley-Usmar V, Davies KJ, Dennery PA, Forman HJ, Grisham MB, Mann GE, Moore K, Roberts LJ 2nd, Ischiropoulos H: Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations. Free Radic Biol Med 2012,52(1):1–6. 10.1016/j.freeradbiomed.2011.09.030PubMed CentralPubMedView ArticleGoogle Scholar
- Eom HJ, Choi J: Oxidative stress of CeO2 nanoparticles via p38-Nrf-2 signaling pathway in human bronchial epithelial cell, Beas-2B. Toxicol Lett 2009,187(2):77–83. 10.1016/j.toxlet.2009.01.028PubMedView ArticleGoogle Scholar
- Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, Sioutas C, Yeh JI, Wiesner MR, Nel AE: Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett 2006,6(8):1794–1807. 10.1021/nl061025kPubMedView ArticleGoogle Scholar
- Wu J, Wang C, Sun J, Xue Y: Neurotoxicity of silica nanoparticles: brain localization and dopaminergic neurons damage pathways. ACS Nano 2011,5(6):4476–4489. 10.1021/nn103530bPubMedView ArticleGoogle Scholar
- Hoefen RJ, Berk BC: The role of MAP kinases in endothelial activation. Vascul Pharmacol 2002,38(5):271–273. 10.1016/S1537-1891(02)00251-3PubMedView ArticleGoogle Scholar
- Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973,52(11):2745–2756. 10.1172/JCI107470PubMed CentralPubMedView ArticleGoogle Scholar
- Chen YH, Lin SJ, Ku HH, Shiao MS, Lin FY, Chen JW, Chen YL: Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-alpha-treated human aortic endothelial cells. J Cell Biochem 2001,82(3):512–521. 10.1002/jcb.1176PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.